AbClon Inc.

With the state-run Korea Drug Development Fund (KDDF), which plays a key role in providing R&D support to the country’s biopharma industry, already midway through its current 10-year term, the fun

Korea’s cell and gene therapy firms are increasingly benefitting from R&D grants given out by a major state-run new drug development fund, amid robust domestic development activities in the sector, al